Effect of Glucagon-like peptide-1 agonist (liriglutide) on weight and glycemic control among adults with type 2 diabetes mellitus attending primary care center at security forces hospital in Riyadh, Saudi Arabia

Effect of Glucagon-like peptide-1 agonist (liriglutide) on weight and glycemic control among adults with type 2 diabetes mellitus attending primary care center at security forces hospital in Riyadh, Saudi Arabia

Introduction: Liraglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist), also known as incretin mimetics. This is the new approach for management of weight among diabetic patients along with glycemic controls. The study aims to explore the efficacy of Liraglutide on weight (...

Full description

Bibliographic Details
Main Authors: Naifah K Alanazi, Medhat A Ghoraba
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
liraglutide
saudi arabia
type ii diabetes
weight loss
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=8;spage=3933;epage=3936;aulast=Alanazi

Similar Items

Similar Items